United States DNA Vaccines Market Report & Forecast 2021-2027

Publisher Name :
Date: 10-Sep-2021
No. of pages: 90
Inquire Before Buying

United States DNA Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Doses)

United States DNA Vaccines Market Segment Percentages, By Type, 2020 (%)

- Recombinant Protein Vaccine

- Gene-Based Vaccine

United States DNA Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Doses)

United States DNA Vaccines Market Segment Percentages, By Application, 2020 (%)

- Human

- Animal

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies DNA Vaccines revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies DNA Vaccines revenues share in United States market, 2020 (%)

Key companies DNA Vaccines sales in United States market, 2016-2021 (Estimated), (K Doses)

Key companies DNA Vaccines sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Merck

- GSK

- Sanofi

- Zoties

- Elanco

- Boehringer-Ingelheim

- Indian Immunologicals

- Plumbline Life Sciences

United States DNA Vaccines Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 DNA Vaccines Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States DNA Vaccines Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States DNA Vaccines Overall Market Size
2.1 United States DNA Vaccines Market Size: 2021 VS 2027
2.2 United States DNA Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 United States DNA Vaccines Sales: 2016-2027
3 Company Landscape
3.1 Top DNA Vaccines Players in United States Market
3.2 Top United States DNA Vaccines Companies Ranked by Revenue
3.3 United States DNA Vaccines Revenue by Companies
3.4 United States DNA Vaccines Sales by Companies
3.5 United States DNA Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 DNA Vaccines Companies in United States Market, by Revenue in 2020
3.7 Manufacturers DNA Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 DNA Vaccines Players in United States Market
3.8.1 List of Tier 1 DNA Vaccines Companies in United States
3.8.2 List of Tier 2 and Tier 3 DNA Vaccines Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States DNA Vaccines Market Size Markets, 2021 & 2027
4.1.2 Recombinant Protein Vaccine
4.1.3 Gene-Based Vaccine
4.2 By Type - United States DNA Vaccines Revenue & Forecasts
4.2.1 By Type - United States DNA Vaccines Revenue, 2016-2021
4.2.2 By Type - United States DNA Vaccines Revenue, 2022-2027
4.2.3 By Type - United States DNA Vaccines Revenue Market Share, 2016-2027
4.3 By Type - United States DNA Vaccines Sales & Forecasts
4.3.1 By Type - United States DNA Vaccines Sales, 2016-2021
4.3.2 By Type - United States DNA Vaccines Sales, 2022-2027
4.3.3 By Type - United States DNA Vaccines Sales Market Share, 2016-2027
4.4 By Type - United States DNA Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States DNA Vaccines Market Size, 2021 & 2027
5.1.2 Human
5.1.3 Animal
5.2 By Application - United States DNA Vaccines Revenue & Forecasts
5.2.1 By Application - United States DNA Vaccines Revenue, 2016-2021
5.2.2 By Application - United States DNA Vaccines Revenue, 2022-2027
5.2.3 By Application - United States DNA Vaccines Revenue Market Share, 2016-2027
5.3 By Application - United States DNA Vaccines Sales & Forecasts
5.3.1 By Application - United States DNA Vaccines Sales, 2016-2021
5.3.2 By Application - United States DNA Vaccines Sales, 2022-2027
5.3.3 By Application - United States DNA Vaccines Sales Market Share, 2016-2027
5.4 By Application - United States DNA Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Overview
6.1.3 Merck DNA Vaccines Sales and Revenue in United States Market (2016-2021)
6.1.4 Merck DNA Vaccines Product Description
6.1.5 Merck Recent Developments
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Overview
6.2.3 GSK DNA Vaccines Sales and Revenue in United States Market (2016-2021)
6.2.4 GSK DNA Vaccines Product Description
6.2.5 GSK Recent Developments
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Overview
6.3.3 Sanofi DNA Vaccines Sales and Revenue in United States Market (2016-2021)
6.3.4 Sanofi DNA Vaccines Product Description
6.3.5 Sanofi Recent Developments
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Overview
6.4.3 Zoties DNA Vaccines Sales and Revenue in United States Market (2016-2021)
6.4.4 Zoties DNA Vaccines Product Description
6.4.5 Zoties Recent Developments
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Overview
6.5.3 Elanco DNA Vaccines Sales and Revenue in United States Market (2016-2021)
6.5.4 Elanco DNA Vaccines Product Description
6.5.5 Elanco Recent Developments
6.6 Boehringer-Ingelheim
6.6.1 Boehringer-Ingelheim Corporation Information
6.6.2 Boehringer-Ingelheim Overview
6.6.3 Boehringer-Ingelheim DNA Vaccines Sales and Revenue in United States Market (2016-2021)
6.6.4 Boehringer-Ingelheim DNA Vaccines Product Description
6.6.5 Boehringer-Ingelheim Recent Developments
6.7 Indian Immunologicals
6.7.1 Indian Immunologicals Corporation Information
6.7.2 Indian Immunologicals Overview
6.7.3 Indian Immunologicals DNA Vaccines Sales and Revenue in United States Market (2016-2021)
6.7.4 Indian Immunologicals DNA Vaccines Product Description
6.7.5 Indian Immunologicals Recent Developments
6.8 Plumbline Life Sciences
6.8.1 Plumbline Life Sciences Corporation Information
6.8.2 Plumbline Life Sciences Overview
6.8.3 Plumbline Life Sciences DNA Vaccines Sales and Revenue in United States Market (2016-2021)
6.8.4 Plumbline Life Sciences DNA Vaccines Product Description
6.8.5 Plumbline Life Sciences Recent Developments
7 United States DNA Vaccines Production Capacity, Analysis
7.1 United States DNA Vaccines Production Capacity, 2016-2027
7.2 DNA Vaccines Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 DNA Vaccines Supply Chain Analysis
9.1 DNA Vaccines Industry Value Chain
9.2 DNA Vaccines Upstream Market
9.3 DNA Vaccines Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 DNA Vaccines Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of DNA Vaccines in United States Market
Table 2. Top DNA Vaccines Players in United States Market, Ranking by Revenue (2019)
Table 3. United States DNA Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States DNA Vaccines Revenue Share by Companies, 2016-2021
Table 5. United States DNA Vaccines Sales by Companies, (K Doses), 2016-2021
Table 6. United States DNA Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers DNA Vaccines Price (2016-2021) & (US$/Dose)
Table 8. Manufacturers DNA Vaccines Product Type
Table 9. List of Tier 1 DNA Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 DNA Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Recombinant Protein Vaccine
Table 12. Major Manufacturers of Gene-Based Vaccine
Table 13. By Type - United States DNA Vaccines Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States DNA Vaccines Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States DNA Vaccines Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States DNA Vaccines Sales (K Doses), 2016-2021
Table 17. By Type - United States DNA Vaccines Sales (K Doses), 2022-2027
Table 18. By Application - United States DNA Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States DNA Vaccines Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States DNA Vaccines Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States DNA Vaccines Sales (K Doses), 2016-2021
Table 22. By Application - United States DNA Vaccines Sales (K Doses), 2022-2027
Table 23. Merck Corporation Information
Table 24. Merck Description and Major Businesses
Table 25. Merck DNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 26. Merck DNA Vaccines Product
Table 27. Merck Recent Developments
Table 28. GSK Corporation Information
Table 29. GSK Description and Major Businesses
Table 30. GSK DNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 31. GSK DNA Vaccines Product
Table 32. GSK Recent Developments
Table 33. Sanofi Corporation Information
Table 34. Sanofi Description and Major Businesses
Table 35. Sanofi DNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 36. Sanofi DNA Vaccines Product
Table 37. Sanofi Recent Developments
Table 38. Zoties Corporation Information
Table 39. Zoties Description and Major Businesses
Table 40. Zoties DNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 41. Zoties DNA Vaccines Product
Table 42. Zoties Recent Developments
Table 43. Elanco Corporation Information
Table 44. Elanco Description and Major Businesses
Table 45. Elanco DNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 46. Elanco DNA Vaccines Product
Table 47. Elanco Recent Developments
Table 48. Boehringer-Ingelheim Corporation Information
Table 49. Boehringer-Ingelheim Description and Major Businesses
Table 50. Boehringer-Ingelheim DNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 51. Boehringer-Ingelheim DNA Vaccines Product
Table 52. Boehringer-Ingelheim Recent Developments
Table 53. Indian Immunologicals Corporation Information
Table 54. Indian Immunologicals Description and Major Businesses
Table 55. Indian Immunologicals DNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 56. Indian Immunologicals DNA Vaccines Product
Table 57. Indian Immunologicals Recent Developments
Table 58. Plumbline Life Sciences Corporation Information
Table 59. Plumbline Life Sciences Description and Major Businesses
Table 60. Plumbline Life Sciences DNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 61. Plumbline Life Sciences DNA Vaccines Product
Table 62. Plumbline Life Sciences Recent Developments
Table 63. DNA Vaccines Production Capacity (K Doses) of Key Manufacturers in United States Market, 2019-2021 (K Doses)
Table 64. United States DNA Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 65. DNA Vaccines Market Opportunities & Trends in United States Market
Table 66. DNA Vaccines Market Drivers in United States Market
Table 67. DNA Vaccines Market Restraints in United States Market
Table 68. DNA Vaccines Raw Materials
Table 69. DNA Vaccines Raw Materials Suppliers in United States Market
Table 70. Typical DNA Vaccines Downstream
Table 71. DNA Vaccines Downstream Clients in United States Market
Table 72. DNA Vaccines Distributors and Sales Agents in United States Market
List of Figures
Figure 1. DNA Vaccines Product Picture
Figure 2. DNA Vaccines Segment by Type
Figure 3. DNA Vaccines Segment by Application
Figure 4. United States DNA Vaccines Market Overview: 2020
Figure 5. United States DNA Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States DNA Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. DNA Vaccines Sales in United States Market: 2016-2027 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by DNA Vaccines Revenue in 2020
Figure 9. Recombinant Protein Vaccine Product Picture
Figure 10. Gene-Based Vaccine Product Picture
Figure 11. By Type - United States DNA Vaccines Sales Market Share, 2016-2027
Figure 12. By Type - United States DNA Vaccines Revenue Market Share, 2016-2027
Figure 13. By Type - United States DNA Vaccines Price (US$/Dose), 2016-2027
Figure 14. Human
Figure 15. Animal
Figure 16. By Application - United States DNA Vaccines Sales Market Share, 2016-2027
Figure 17. By Application - United States DNA Vaccines Revenue Market Share, 2016-2027
Figure 18. By Application - United States DNA Vaccines Price (US$/Dose), 2016-2027
Figure 19. Merck DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. GSK DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Sanofi DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Zoties DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Elanco DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Boehringer-Ingelheim DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Indian Immunologicals DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Plumbline Life Sciences DNA Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. United States DNA Vaccines Production Capacity (K Doses), 2016-2027
Figure 28. DNA Vaccines Industry Value Chain
Figure 29. Marketing Channels
  • 2021-2027 Global and Regional Minocycline Hydrochloride Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 150
    The global Minocycline Hydrochloride market was valued at 16.93 Million USD in 2020 and will grow with a CAGR of 1.2% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia,......
  • 2021-2027 Global and Regional Indocyanine Green Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Sep-2021        Price: US 3500 Onwards        Pages: 146
    The global Indocyanine Green market was valued at 45.19 Million USD in 2020 and will grow with a CAGR of 4.1% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe,......
  • United States Rabies Vaccine Market Report & Forecast 2021-2027
    Published: 22-Sep-2021        Price: US 3400 Onwards        Pages: 94
    United States Rabies Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Rabies Vaccine Market Segment Percentages, By Type, 2020 (%) - Vero Cell Rabies Vaccine - BHK - Chick Embryo Cell Rabies Vaccine - Others United States Rabies Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Rabies Vaccine Market Segment Percentages, By Application, 2020 (%) - Pre-expos......
  • United States PVP Iodine Market Report & Forecast 2021-2027
    Published: 22-Sep-2021        Price: US 3400 Onwards        Pages: 91
    United States PVP Iodine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT) United States PVP Iodine Market Segment Percentages, By Type, 2020 (%) - Medical Grade PVP Iodine - Industrial Grade PVP Iodine United States PVP Iodine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT) United States PVP Iodine Market Segment Percentages, By Application, 2020 (%) - Medical Use - Food Industry - Breed Industry - O......
  • United States Prostacyclin Market Report & Forecast 2021-2027
    Published: 22-Sep-2021        Price: US 3400 Onwards        Pages: 92
    United States Prostacyclin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Unit) United States Prostacyclin Market Segment Percentages, By Type, 2020 (%) - Epoprostenol Sodium - Treprostinil - Iloprost - Beraprost Sodium United States Prostacyclin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Unit) United States Prostacyclin Market Segment Percentages, By Application, 2020 (%) - For Injection - For Or......
  • United States Procalcitonin (CAS 56645-65-9) Market Report & Forecast 2021-2027
    Published: 22-Sep-2021        Price: US 3400 Onwards        Pages: 106
    United States Procalcitonin (CAS 56645-65-9) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (mg) United States Procalcitonin (CAS 56645-65-9) Market Segment Percentages, By Type, 2020 (%) - Procalcitonin Antigen - Procalcitonin Antibody United States Procalcitonin (CAS 56645-65-9) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (mg) United States Procalcitonin (CAS 56645-65-9) Market Segment Percentages, By Application, 2020 (%) ......
  • United States Povidone Iodine (PVP-I) Market Report & Forecast 2021-2027
    Published: 22-Sep-2021        Price: US 3400 Onwards        Pages: 93
    United States Povidone Iodine (PVP-I) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Povidone Iodine (PVP-I) Market Segment Percentages, By Type, 2020 (%) - Medical Grade PVP-I - Industrial Grade PVP-I United States Povidone Iodine (PVP-I) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Povidone Iodine (PVP-I) Market Segment Percentages, By Application, 2020 (%) - Skin Sterilization -......
  • United States Polio Vaccine Market Report & Forecast 2021-2027
    Published: 22-Sep-2021        Price: US 3400 Onwards        Pages: 93
    United States Polio Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Polio Vaccine Market Segment Percentages, By Type, 2020 (%) - Inactivated Polio Vaccine (IPV) - Oral Polio Vaccine (OPV) United States Polio Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Polio Vaccine Market Segment Percentages, By Application, 2020 (%) - Public - Private Comp......
  • United States Podophyllin Market Report & Forecast 2021-2027
    Published: 22-Sep-2021        Price: US 3400 Onwards        Pages: 93
    United States Podophyllin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kg) United States Podophyllin Market Segment Percentages, By Type, 2020 (%) - 50% of Podophyllin United States Podophyllin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kg) United States Podophyllin Market Segment Percentages, By Application, 2020 (%) - Podophyllotoxin Tincture - Podophylloto......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs